OHSU Startup Companies OHSU Technology Transfer has assisted in the launch of numerous startup companies based on OHSU research and technologies. Read more about each company and how they’re impacting the community with their OHSU-based innovations. 13therapeutics, Inc. is a research and drug development company identifying, characterizing, and optimizing novel anti-inflammatory peptide therapeutics for unmet medical needs. Acute Innovations provides implants and instruments for chest wall stabilization surgical procedures. Products are sold globally and include RibLoc(R) Rib Fracture Plating, RibLoc(R) U Plus Chest Wall Plating System, BioBridge(R) Chest Wall Reconstruction Plate, and AcuTie(R) Sternum Closure System. Advanced PsychSystems provides software to facilitate delivery of personalized behavioral health care. AMES Technology Inc. has developed and is bringing to market a new non-invasive, patented technology which has been shown in clinical trials to reduce impairment and improve function in highly disabled stroke patients and incomplete spinal cord injured patients. APDM Wearable Technologies, a translational research company focused on discovering reliable & sensitive endpoints of disease progression in neurological & chronic conditions by quantifying human movement with wearable sensors. Aronora, Inc. is a translational biotechnology company that is developing safe proprietary antithrombotic (“blood-thinning”) biological drugs. Artielle Immunotherapeutics, Inc. is developing a novel, first-in-class platform of biological molecules to treat inflammatory and degenerative diseases. Information coming soon. BioSpeech, Inc. is creating speech technology based software solutions for people with language, speech, hearing, breathing problems. Ceremod, Inc. is an Oregon research and development company focused on implantable deep brain stimulation (DBS) devices to treat a variety of medical conditions. Ceremod's focus is to develop DBS as a treatment of severe obesity. CBDS Health, Inc. is a complete solution for the Internet of Medical Things (IoMT) with early application focus in research, clinical trials and precision medicine. Transforming cancer care through clear and actionable insights. Cylerus, Inc. develops implantable, sirolimus-eluting cuff and reservoir systems to solve the clinical problem of vascular graft failure. CytoImage Dx develops imaging diagnostics for drug screening and personalized detection of disease. Cytotheryx is a biomedical research company focused on the development of a consistent, high-quality source of human hepatocytes (HHCs) and the application of those HHCs for multiple research and clinical applications. Information coming soon. Fennec Pharmaceuticals is a small stage biotechnology company focused on the development of PEDMARKTM (a unique formulation of Sodium Thiosulfate) for the prevention of ototoxicity from cisplatin in pediatric patients. First Ascent Biomedical develops personalized cancer treatment plans for individuals based on the biology of their tumor and the response to multi-drug combinations. Genefac, Inc. is a Mass Transcription Factor analysis company. GoBiquity, Inc. provides innovative mobile technology and diagnostics bringing actionable specialty testing to primary care, so physicians can be more effective and efficient at providing preventative care and early detection for their patients. Information coming soon. MolecularMD Corp. develops and commercializes specialty molecular diagnostics for oncology applications. Its tests are designed to allow appropriate selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. MotioSens provides smart home technology that unobtrusively monitors daily activities of people living independently. Najit Technologies, Inc. utilizes a novel oxidation-based vaccine production system, HydroVax™, that results in superior vaccine formulations for infectious disease as compared to conventional methods. NervGen is restoring life's potential by creating innovative solutions for the treatment of nerve damage. NeuraMedica focuses on the development of a novel, bioabsorbable surgical clip for durotomy closure. NwETA provides superior training and assessment/testing products that we developed and tested extensively in NIH- and CDC-supported research grants. NOUS Imaging, a St. Louis-based, software biofeedback solution startup company working to improve brain MR exams. Nzumbe, Inc. provides research services to solve the needs of pharmaceutical companies and accelerate the development of breakthrough therapies in challenging diseases such as cancer and psychiatric disease. Nzumbe's focus is on preventing and reversing the epigenetic causes of disease. OmnEcoil operates in the surgical and medical instruments business. Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. PDX Pharmaceuticals focuses on developing functionalized nanomaterials into drugs. Information coming soon. Information coming soon. QuantiPort provides objective blood volume information to physicians. ServerDome develops new self-sustained data storage center designed to eliminate maintenance and reduce energy footprint. The SimHealth Group, is a full service simulation facility design, instructor training, program assessment, development, and implementation group. Spoonbill Foundation discovers, develops, and delivers therapeutics for PKAN and all NBIA disorders in partnership with the NBIA community, as swiftly as possible and at the lowest cost. SurgiVance Inc. provides advanced imaging for surgical guidance. United in Heart creates tools to empower everyday people to solve climate change and significantly reduce world hunger. Information coming soon. Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Virogenomics Biodevelopment, Inc. partners with inventors of early pre-clinical stage technologies in order to evaluate and develop commercial products. Virogenomics works closely with inventors until the technology becomes attractive to larger investment. ViTi, Inc. works to improve T cell diagnostic technology. The company is currently developing diagnostic technologies for infectious diseases with a focus on tuberculosis. Yecuris, Inc. is a biotechnology company focused on the utilization of humanized model systems for pre-clinical drug development and human disease modeling.